Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Nkarta drops another cancer program as it leans into autoimmune disease
7 months ago
R&D
Athira gives up on lead Alzheimer’s drug, switches tack to ALS
7 months ago
R&D
Pfizer to invest $1B in China over next five years — reports
7 months ago
Financing
China
Senior AstraZeneca exec detained in China amid wider investigation
7 months ago
People
China
Stephen Squinto's JPM life sciences team is raising a new fund for later-stage companies
7 months ago
Financing
Startups
Soft RSV sales reveal a vaccine market failing to catch post-Covid momentum
7 months ago
Pharma
FDA+
FDA seeks to pull OTC nasal decongestant ingredient due to lack of efficacy
7 months ago
Pharma
FDA+
Coherus restarts biosimilar supply after delays; Novavax ends Covid vaccine deal with UK
7 months ago
Manufacturing
Genmab chops early cancer prospects to prioritize Phase 3 projects
7 months ago
R&D
Pharma
Aurinia cuts nearly half of its workforce in second round of layoffs this year
7 months ago
R&D
Geron’s royalty deal; Minghui’s new VEGF bispecific data
7 months ago
News Briefing
Denali teases early data for enzyme replacement therapy in rare disease
7 months ago
R&D
Q&A: Demis Hassabis talks winning the Nobel Prize, building an AI biotech sans lab, and Trump’s potential impact
7 months ago
People
AI
Avid Bioservices to be sold to private equity firms for $1.1B
7 months ago
Deals
Manufacturing
How Menlo Ventures thinks AI in health tech is going to be commoditized
7 months ago
AI
Health Tech
Gilead beats Covid drug sales forecasts, takes $1.75B hit on Trodelvy study fail
7 months ago
R&D
Pharma
Arcus backs TIGIT combo by offering glimpse at positive data from axed trial
7 months ago
R&D
Joe Jimenez's latest Aditum company lines up T cell engager from China
7 months ago
Startups
Deals
Moderna reports slow start to RSV sales as Bancel steps back from commercial role
7 months ago
People
Pharma
Sarepta discontinues work on next-gen exon-skipping drug for Duchenne
7 months ago
R&D
California voters say yes to restrictions around 340B spending
7 months ago
Pharma
FDA+
GSK CEO Emma Walmsley on the new Trump administration, trust, AI and China
7 months ago
People
China
Studies show how once-obscure DNA circles drive cancer, and maybe even how to stop them
7 months ago
Discovery
CVS names Aetna head, plans more pharmacy closures as new CEO takes over
7 months ago
People
Pharma
First page
Previous page
79
80
81
82
83
84
85
Next page
Last page